پرش به محتوای اصلی

CRISPR-Cas9

CRISPR-Engineered Blood Stem Cells Open a New Frontier for Precision Cancer Immunotherapy

CRISPR-Engineered Blood Stem Cells Open a New Frontier for Precision Cancer Immunotherapy

Gene-edited donor hematopoietic stem and progenitor cells enable targeted AML treatment with gemtuzumab ozogamicin while shielding and preserving healthy blood formation....

Read Article →